Policy Number

7.20

IWK - 7.20 Quality Assurance for Hazardous Sterile Products - Environmental Monitoring in 6 Link Pharmacy

Description

Environmental monitoring will occur as part of a quality management program that includes validation of facilities, equipment and personnel. The facilities used to compound hazardous cytotoxic sterile preparations shall meet the conditions required for contamination-free compounding of hazardous sterile products. Monitoring will involve air and surface sampling for microbial and particle contamination, and wipe test sampling for hazardous drug contamination.